Next Article in Journal
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells
Previous Article in Journal
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
 
 
Article

Article Versions Notes

Cancers 2022, 14(7), 1806; https://doi.org/10.3390/cancers14071806
Action Date Notes Link
article pdf uploaded. 1 April 2022 17:37 CEST Version of Record https://www.mdpi.com/2072-6694/14/7/1806/pdf-vor
article xml file uploaded 2 April 2022 09:01 CEST Original file -
article xml uploaded. 2 April 2022 09:01 CEST Update -
article pdf uploaded. 2 April 2022 09:01 CEST Updated version of record https://www.mdpi.com/2072-6694/14/7/1806/pdf-vor
article html file updated 2 April 2022 09:02 CEST Original file -
article xml file uploaded 10 April 2022 08:17 CEST Update -
article xml uploaded. 10 April 2022 08:17 CEST Update https://www.mdpi.com/2072-6694/14/7/1806/xml
article pdf uploaded. 10 April 2022 08:17 CEST Updated version of record https://www.mdpi.com/2072-6694/14/7/1806/pdf
article html file updated 10 April 2022 08:18 CEST Update -
article supplementary file uploaded. 21 April 2022 13:42 CEST - https://www.mdpi.com/2072-6694/14/7/1806#supplementary
article html file updated 2 August 2022 17:01 CEST Update https://www.mdpi.com/2072-6694/14/7/1806/html
Back to TopTop